- mail us help@24marketresearch.com
- Int'l 1(332) 2424 294 (Int'l)
TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The global Lanreotide Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes TSH. Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.
This report aims to provide a comprehensive presentation of the global market for Lanreotide Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lanreotide Injection. This report contains market size and forecasts of Lanreotide Injection in global, including the following market information:
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Sustained Release Formulation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lanreotide Injection include Ipsen and Cipla etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lanreotide Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lanreotide Injection Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Lanreotide Injection Market Segment Percentages, by Type, 2022 (%)
Global Lanreotide Injection Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Lanreotide Injection Market Segment Percentages, by Application, 2022 (%)
Global Lanreotide Injection Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Lanreotide Injection Market Segment Percentages, By Region and Country, 2022 (%)
The report also provides analysis of leading market participants including:
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lanreotide Injection, market overview.
Chapter 2: Global Lanreotide Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Lanreotide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lanreotide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lanreotide Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.